Krystal Biotech, Inc.
(KRYS - NASDAQ)
270,50 USD
📋 Profilo Aziendale

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States.

|